Mouse models address key concerns regarding autophagy inhibition in cancer therapy

Cancer Discovery

Volumn 4, Issue 8, 2014, Pages 873-875

  Amaravadi, Ravi ^a   Debnath, Jayanta ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; HYDROXYCHLOROQUINE; PROTEIN P53; GLUCOSE; TP53 PROTEIN, HUMAN;

ARTICLE; ATG5 GENE; ATG7 GENE; AUTOPHAGY; CANCER THERAPY; CLINICAL TRIAL (TOPIC); DISEASE MODEL; DRUG TARGETING; GENE; GENE DELETION; GENE MUTATION; GENETICALLY ENGINEERED MOUSE STRAIN; LUNG CANCER; NEOPLASM; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; PROTEIN PROTEIN INTERACTION; TREATMENT RESPONSE; TRP53 GENE; TUMOR GROWTH; ANIMAL; CELL TRANSFORMATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; PANCREAS TUMOR;

ANIMALS; AUTOPHAGY; CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; GLUCOSE; HUMANS; LUNG NEOPLASMS; PANCREATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84905493200     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-14-0618     Document Type: Article

References (10)

1. Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev 2011;25:1999-2010.
2. Yang A, Rajeshkumar NV, Wang X, Yabuuchi S, Alexander BM, Chu GC, et al. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov 2014;4:905-13.
3. Karsli-Uzunbas G, Guo JY, Price S, Teng X, Laddha SV, Khor S, et al. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov 2014;4:914-27.
4. Guo JY, Karsli-Uzunbas G, Mathew R, Aisner SC, Kamphorst JJ, Strohecker AM, et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev 2013;27:1447-61.
5. Strohecker AM, Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ, Mathew R, et al. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov 2013;3:1272-85.
6. Rosenfeldt MT, O'Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013;504:296-300.
7. Iacobuzio-Donahue CA, Herman JM. Autophagy, p53, and pancreatic cancer. N Engl J Med 2014;370:1352-3.
8. Rangwala R, Leone R, Chang C, Fecher L, Schucter L, Kramer A, et al. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy 2014;10(8). [Epub ahead of print].
9. Rosenfeld MR, Ye X, Supko JG, Desideri S, Grossman SA, Brem S, et al. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy 2014;10(8). [Epub ahead of print].
10. Vogl DT, Stadtmauer EA, See Tan K, Heitjan DF, Davis LE, Pontiggia L, et al. Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/ refractory myeloma. Autophagy 2014;10(8). [Epub ahead of print].